GeNeuro S.A. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
- |
Public Float |
- |
GeNeuro S.A. | |
Stock Exchange | Euronext Paris |
EPS |
EUR0.57 |
Market Cap |
EUR50.83 M |
Shares Outstanding |
14.66 M |
Public Float |
2 M |
Address |
3, Chemin du Pré-Fleuri Plan-les-Ouates Geneve (Geneva) 1228 Switzerland |
Employees | - |
Website | http://www.geneuro.ch/fr/accueil |
Updated | 07/08/2019 |
GeNeuro SA engages in the research and development of pharmaceutical products. It offers GNbAC1, a therapeutic antibody that targets MSRV-Env. It also offers a drug for multiple sclerosis. |